Indiana IN
Eli Lilly Says Anti-Inflammatory Drug May Shorten COVID-19 Recovery Time
Eli Lilly announced the results Monday from a 1,000-person study sponsored by the U.S. National Institute of Allergy and Infectious Diseases. The result have not yet been published…